Life Sciences and Transformational Health

  Increasing hospitalizations, anticipated rise in cancer incidence, and higher demand for infused chemotherapy agents are fuelling the need for higher quality catheters for safe usage. Furthermore, rising number of biologic approvals is increasing the demand for infusion therapies. The global peripheral intravenous catheters market was valued at   US$ 4.9 Bn  in  2020 , and is expected to witness a healthy   CAGR of 7%  during the forecast period ( 2020 – 2030 ). Strategizing The Moves For The Next Decade? See Through Sample Of Peripheral Intravenous Catheter Market Report!  https://www.persistencemarketresearch.co/samples/3324 Companies covered in Peripheral Iv Catheter Market Report Becton, Dickinson and Company B. Braun Melsungen AG Smiths Group plc. Terumo Corporation Venner Medical Vygon Teleflex Incorporated C. R. Bard, Inc. NIPRO Medical Corporation Argon Medical Devices, Inc. Starting With The New Decade On A Diligent Note ...

  Monotherapy is cost-effective and gives deliverable action directly to the site of action in a few minutes, and is said to be a safe and effective method for treating idiopathic pulmonary fibrosis (IPF). According to Persistence Market Research (PMR), request for pulmonary fibrosis treatment is predicted to increase, enabling the market to surpass US$ 2.7 Bn by 2021. Over the coming years, rising cases of IPF will support the expansion of the market. Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/30070 High number of research & development projects, increasing investments, and favorable regulatory policies are some other factors supporting growth of the market for pulmonary fibrosis treatment. Majority of the population living with pulmonary fibrosis is being treated with traditional corticosteroid combination drugs with limited efficacy. With the arrival of new novel therapies, unaddressed populations in middle- and lower-income countries...

  According to a new market report published by Persistence Market Research “Global Market Study on   Ophthalmic Devices : Asia to Witness Highest Growth by 2020,” the global ophthalmic devices market was valued at USD 29,171.5 million in 2014 and is expected to grow at a   CAGR of 6.5% from   2014 to 2020, to reach an estimated value of   USD 42,685.1 million   in 2020. Globally, the ophthalmic devices market is witnessing significant growth due to increasing prevalence of eye disorders, such as diabetic retinopathy and macular degeneration. In addition, growing global aging population, increasing government initiatives towards healthcare infrastructure in developing countries, and increasing incidence of lifestyle-associated diseases are also driving the growth of the market. Planning Forward? Access Sample Of Ophthalmic Devices Market Report!  https://www.persistencemarketresearch.co/samples/3188 Some of the major players in the global ophthalmic de...

  Endoscopic Submucosal Dissection (ESD) has witnessed slow adoption in Western countries in the past. This is due to the continued referral of patients for surgery or Endoscopic Mucosal Resection (EMR) procedures. Furthermore, ESD demands highly skilled and trained professionals. Although the procedure is difficult to learn and the training is expensive, a small group of endoscopists in Western countries are becoming more interested. These endoscopists are working toward training in a Japanese centre to learn from experts. This change is expected to increase the adoption rate of  endoscopic submucosal dissection  over the coming years. Strategizing The Moves For The Next Decade? See Through Sample Of Endoscopic Submucosal Dissection Market Report!  https://www.persistencemarketresearch.co/samples/22897 Company Profiles Olympus Corporation Boston Scientific Corporation ERBE Elektromedizin GmbH FUJIFILM Medical Systems U.S.A., Inc Sumitomo Bakelite Co., Ltd Ovesco End...

  Increasing adoption of mesotherapy for skin rejuvenation procedures across developed and developing countries, due to increasing product availability, is expected to drive the growth of the mesotherapy market. Also, the availability of different variants of mesotherapy products, including creams, masks, peels, solutions, and dermal fillers provides extensive options to consumers. The minimally-invasive nature of mesotherapy, easier product availability, and cost effectiveness are key factors propelling revenue growth. Rise in medical tourism along with increasing disposable income in countries such as Brazil, India, and China is expected to offer further impetus to market growth during the forecast period of  2019  to  2029 . Get Going With Sample Of Mesotherapy Market Report!  https://www.persistencemarketresearch.co/samples/30409 Companies covered in Mesotherapy Market Report Laboratoires FILORGA SA INSTITUTE BCN mesoskinline Koru Pharmaceuticals Co., L...

Persistence Market Research Released New Market Report on “Global Market Study on Insulin Delivery Devices - Asia to Witness Highest Growth by 2020” the global insulin delivery devices market is estimated at USD 9,391.1 million in 2014 and is expected to grow at a  CAGR of 7%  from 2014 to 2020, to reach an estimated value of  USD 14,093.3 million in 2020 . The insulin delivery devices market is witnessing a significant growth due to the increasing prevalence of diabetes and rising obese endemic. In addition, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting in the growth of the global insulin delivery devices market. Get Going With Sample Of Insulin Delivery Device Market Report!  https://www.persistencemarketresearch.co/samples/2823 Some of the major players operating in the market: Abbott Laboratories. Novo Nordisk A/S. Eli Lilly and Company. Medtronic, Inc. Sanofi, Becton. Dickinson and Company...

  The  skin barriers market  is a niche market, and is a consolidated space with many major players. The parent market for skin barriers is incontinence and ostomy. Skin barriers generally fall under accessory products offered by companies to complement healing and facilitate skin protection. The potential of the skin barriers market has not yet been fully tapped because of products being less focused on and marketed. The ongoing  COVID-19  pandemic is expected to have limited impact on the global skin barriers market. Ostomy procedures and medical diagnosis of incontinence are being postponed due to more pressing needs related to coronavirus. However, due to lockdown conditions, the online sales channel is expected to aid market growth. Persistence Market Research estimates that the global skin barriers market is set to witness a CAGR of  4%  over the forecast period ( 2020-2030 ). Get Going With Sample Of Skin Barriers Market Report!  https://ww...

  According to the latest market report published by Persistence Market Research, titled “Asia Pacific Alopecia Treatment Market: Industry Analysis and Forecast (2016–2024)”, revenue from the Asia Pacific alopecia treatment market is expected to expand at a   CAGR of 6.6%   during the forecast period 2016 - 2024. In the report, the Asia-Pacific alopecia treatment market is analyzed on the basis of, type of alopecia, treatment type, and end user. On the basis of the type of alopecia, the overall market has been segmented into alopecia areata, alopecia totalis, and alopecia universalis. Topical drugs (creams, oils, lotions, gels, shampoos, and foam), oral drugs, injectable (platelet rich plasma therapy, steroid, and injectable fillers), hair transplant services and low-level laser therapy form the basis of treatment type. Get Going With Sample Of Asia Pacific Alopecia Treatment Market Report!  https://www.persistencemarketresearch.co/samples/11077 Key Players Teva Phar...

  Persistence Market Research (PMR), in a recent report, “Global Market Study on   Hemodynamic Monitoring System: Growing Demand for Critical Congenital Heart Disease Screening to Drive the Market   by 2021 ”, projected the hemodynamic monitoring systems market to expand at a healthy   CAGR of 6.5%   during the forecast period. The report offered trends driving the market and delivered analysis and insights on the potential of the hemodynamic monitoring systems market in specific regions. In terms of revenue, the hemodynamic monitoring systems market was valued at US$ 328.7 Mn in 2014 and is projected to reach  US$ 508.4 Mn by 2021 . Factors driving market growth include government and private sector initiatives to reduce healthcare costs, rising prevalence of lifestyle diseases, growing the geriatric patient population, increasing the incidence of respiratory disorders and growing demand for the screening of critical congenital heart disease (CCHD). How Ab...